Buy Keros Therapeutics Stock | KROS Stock Price & Latest News | Public
KROS

Keros Therapeutics

$0.00 (0.00%)Today

    About KROS

    Keros Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on treatments for rare muscle diseases. The company was founded in 2015 and is headquartered in Lexington, MA. The full company name is Keros Therapeutics, Inc....

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -1.7
    -3.41
    -5.11
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.67

    Actual EPS
    Q3 2020

    Stats

    Market Cap$724,74M
    Volume350
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$42.26
    1 Year Low$19.10
    Open$35.24
    High$35.31
    Low$34.91

    Buy any stock with any amount of money.

    Download the App
    Download the app